Novo NordisksU.S.-listed shares were paring earlier losses after the Danish drugmaker released its second-quarter earnings a day early. Copyright ©2026Dow Jones & Company, Inc. All Rights Reserv⦠[+35 chars]
No comments yet. Be the first to comment!